NICE

News

Vydura is NHS’ first oral CGRP for migraine prevention

Pfizer’s Vydura has become the first oral CGRP antagonist recommended for routine use by the NHS to prevent episodic migraine attacks, after being rejected earlier this ye

News

NHS will roll out ‘lifeline’ endometrial cancer regimen

The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-ex

News

Cara, CSL Vifor’s CKD itching drug, backed for NHS use

Some patients in the UK with chronic kidney disease (CKD) who develop chronic itching – one of the most common and challenging side effects of dialysis – will soon be able

News

Digital depression, anxiety therapies backed for NHS use

NICE has followed through on plans to make a series of digital therapeutics (DTx) for adults with anxiety disorders or depression in England, although it acknowledges more

News

NICE okays glucose sensors in kids with type 2 diabetes

Children with type 2 diabetes in the UK who have to undergo the stressful chore of monitoring blood glucose with multiple finger prick blood tests every day could soon see

News

Otsuka’s lupus nephritis drug Lupkynis backed for NHS use

Patients in England and Wales with active lupus nephritis will soon be able to access treatment with Otsuka Pharma’s Lupkynis following a recommendation by the health tech

Vydura is NHS’ first oral CGRP for migraine prevention

NHS will roll out ‘lifeline’ endometrial cancer regimen

Cara, CSL Vifor’s CKD itching drug, backed for NHS use

Digital depression, anxiety therapies backed for NHS use

NICE okays glucose sensors in kids with type 2 diabetes

Otsuka’s lupus nephritis drug Lupkynis backed for NHS use

Hims & Hers buys Australian digital health firm for $1.15bn

How to meet your physicians where they are online

NICE

Editor's Picks